These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18692574)

  • 21. PirB is a functional receptor for myelin inhibitors of axonal regeneration.
    Atwal JK; Pinkston-Gosse J; Syken J; Stawicki S; Wu Y; Shatz C; Tessier-Lavigne M
    Science; 2008 Nov; 322(5903):967-70. PubMed ID: 18988857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
    Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
    Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity.
    Raiker SJ; Lee H; Baldwin KT; Duan Y; Shrager P; Giger RJ
    J Neurosci; 2010 Sep; 30(37):12432-45. PubMed ID: 20844138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
    Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
    Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth.
    Kottis V; Thibault P; Mikol D; Xiao ZC; Zhang R; Dergham P; Braun PE
    J Neurochem; 2002 Sep; 82(6):1566-9. PubMed ID: 12354307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of neuronal repair and regeneration through inhibition of oligodendrocyte myelin glycoprotein (OMgp).
    Choudhary P; Gupta S; Shukla R; Gupta A; Pahal S; Singh S
    J Biomol Struct Dyn; 2022; 40(24):13936-13952. PubMed ID: 34787055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    Li S; Strittmatter SM
    J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.
    Peng X; Zhou Z; Hu J; Fink DJ; Mata M
    J Biol Chem; 2010 Jan; 285(4):2783-95. PubMed ID: 19901030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration.
    Kempf A; Montani L; Petrinovic MM; Schroeter A; Weinmann O; Patrignani A; Schwab ME
    Eur J Neurosci; 2013 Dec; 38(11):3567-79. PubMed ID: 24103058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
    Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
    Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
    Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
    Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon.
    Gil V; Bichler Z; Lee JK; Seira O; Llorens F; Bribian A; Morales R; Claverol-Tinture E; Soriano E; Sumoy L; Zheng B; Del Río JA
    Cereb Cortex; 2010 Aug; 20(8):1769-79. PubMed ID: 19892785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
    Huang JY; Wang YX; Gu WL; Fu SL; Li Y; Huang LD; Zhao Z; Hang Q; Zhu HQ; Lu PH
    Brain Res; 2012 Feb; 1437():1-15. PubMed ID: 22227458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
    Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
    J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
    Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
    Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
    Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligodendrocytic but not neuronal Nogo restricts corticospinal axon sprouting after CNS injury.
    Meves JM; Geoffroy CG; Kim ND; Kim JJ; Zheng B
    Exp Neurol; 2018 Nov; 309():32-43. PubMed ID: 30055160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity.
    Weiss J; Takizawa B; McGee A; Stewart WB; Zhang H; Ment L; Schwartz M; Strittmatter S
    Exp Neurol; 2004 Sep; 189(1):141-9. PubMed ID: 15296844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.